Exercise and rest technetium-99m-tetrofosmin lung uptake: Correlation with left ventricular ejection fraction in patients with coronary artery disease

Japanese Heart Journal

Volumn 43, Issue 5, 2002, Pages 515-522

  Tsou, Shi Sheng ^a   Sun, Shung Shung ^a   Kao, Albert ^a   Lin, Cheng Chieh ^a   Lee, Cheng Chun ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Left ventricular ejection fraction; Lung to heart uptake ratio; Technetium 99m tetrofosmin

Indexed keywords

TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DRUG UPTAKE; EXERCISE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; EXERCISE TEST; HEART STROKE VOLUME; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING;

ADULT; AGED; CORONARY DISEASE; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REST; STROKE VOLUME; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULOGRAPHY, FIRST-PASS;

EID: 0036718902     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.43.515     Document Type: Article

References (26)

1. Cohn PF, Braunwald EB. Chronic coronary disease. In: Braunwald EB, editor. Heart Disease. Philadelphia: WB Saunders 1980; 1387-436.
2. Brown KA, Boucher CA, Okada RD, et al. Prognostic value of exercise-thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1984; 1: 994-1001.
3. Liu P, Kiess M, Okada RD, et al. Increased thallium lung uptake after exercise in isolated left anterior descending coronary artery disease. Am J Cardiol 1985; 55: 1469-73.
4. O'Rourke RA. Lung uptake of thallium as a prognostic indicator [Editorial]. N Engl J Med 1987; 317: 1532-4.
5. Jain D, Lahiri A, Raftery EB. Clinical and prognostic significance of lung thallium uptake on rest imaging in acute myocardial infarction. Am J Cardiol 1990; 65: 154-9.
6. Gibson RS, Watson DD. Value of planar 201T1 imaging in risk stratification of patients recovering from acute myocardial infarction. Circulation 1991; 84(Suppl): 1148-62.
7. Canhasi B, Dae M, Botvinick E, et al. Interaction of "supplementary" scintigraphic indicators of ischemia and stress electrocardiography in the diagnosis of multivessel coronary disease. J Am Coll Cardiol 1985; 6: 581-8.
8. Nordrehaug JE, Danielsen R, Vik-Mo H. Physiological inverse relationship between heart rate and thallium-201 lung uptake, clearance and lung/myocardial uptake ratio. Ear Heart J 1990; 11: 628-33.
9. Baillet GY, Mena IG, Kuperus JH, et al. Simultaneous technetium-99m-MIBI angiography and myocardial perfusion imaging. J Nucl Med 1989; 30: 38-44.
10. Bisi G, Sciagra R, Bull U, et al. Assessment of ventricular function with first-pass radionuclide angiography using technetium-99m-hexakis-2-methoxyisobutyl: a European multicentre study. Eur J Nucl Med 1991; 18: 178-83.
11. Sciaga R, Bisi G, Santoro GM, Briganti V, Leoncini M, Fazzini PF. Evaluation of coronary artery disease extent and severity using 99mTc-sestamibi first-pass and perfusion imaging in combination with dipyridamole infusion. J Nucl Med 1994; 35: 1254-64.
12. Bacher-Stier C, Sharir T, Kavanagh PB, et al. Postexercise lung uptake of Tc-99m-sestamibi determined by a new automatic technique: validation and application in detection of severe and extensive coronary artery disease and reduced left ventricular function. J Nucl Med 2000; 41: 1190-7.
13. Hurwitz GA, Ghali SK, Husni M, et al. Pulmonary uptake of technetium-99 sestamibi induced by dipyridamole-based stress or exercise. J Nucl Med 1998; 39: 339-45.
14. Giubbini R, Campini R, Milan E, et al. Evaluation of technetium-99m-sestamibi lung uptake: correlation with left ventricular function. J Nucl Med 1995; 36: 58-63.
15. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis(bis(2-ethoxyethyl)phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-8.
16. Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-7.
17. Kao CH, Shen YY, Lee JK. Effects of smoking on pulmonary uptake of technetium-99m methoxyisobutylisonitrile during myocardial perfusion imaging. J Nucl Cardiol 1999; 16: 29-32.
18. Bingham JB, McKusick KA, Strauss HW, et al. Influence of coronary artery disease on pulmonary uptake of thallium-201. Am J Cardiol 1980; 146: 821-6.
19. Tamaki N, Itoh H, Ishii Y, et al. Hemodynamic significance of increased lung uptake of thallium-201. Am J Roentgenol 1982; 338: 22-8.
20. Mimaiji K, Maeda K, Nakashima Y, et al. Assessment of left ventricular dysfunction by thallium-201 lung uptake during exercise in coronary artery disease. Jpn Circ J 1983; 47: 381-90.
21. Korhendler JA, Poucher CA, Strauss HW, et al. Decrease in the ability to detect elevated lung thallium due to delay in commencing imaging after exercise. Am Heart J 1985; 110: 830-5.
22. Carvalho PA, Chiu ML, Kronauge JF, et al. Subcellular distribution and analysis of technetium-99m-MIB1 in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-21.
23. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutyisonitrile) technetium (1) in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-53.
24. Taillefer R, Primeau M, Costi P, Lambert R, Leveille J, Latour Y. Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3- hour) postexercise images. J Nucl Med 1991; 32: 1961-5.
25. Villanueva-Meyer J, Mena I, Diggles L, Narahara KA. Assessment of myocardial perfusion defect size after early and delayed SPECT imaging with technetium-99m-hexakis 2-methoxyisobutyl isonitrile after stress. J Nucl Med 1993; 34: 187-92.
26. Tanigaki K, Kobayashi H, Momose M, et al. Clinical utility of pulmonary Tc-99m-tetrofosmin uptake measurement by exercise myocardial scintigraphy in patients with ischemic heart disease [in Japanese]. Kaku Igaku (Nuclear Medicine) 1998; 35: 189-95.